Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118939672 | 11893967 | 2 | F | 199812 | 20160826 | 20160107 | 20160829 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10602928 | BRISTOL MYERS SQUIBB | 2.53 | YR | M | Y | 3.90000 | KG | 20160829 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118939672 | 11893967 | 1 | PS | VIDEX | DIDANOSINE | 1 | Transplacental | UNK | U | 20156 | |||||||||
| 118939672 | 11893967 | 2 | SS | VIDEX | DIDANOSINE | 1 | Oral | U | 20156 | ||||||||||
| 118939672 | 11893967 | 3 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118939672 | 11893967 | 4 | SS | RETROVIR | ZIDOVUDINE | 1 | Oral | U | 0 | ||||||||||
| 118939672 | 11893967 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118939672 | 11893967 | 6 | C | VITAMINS | VITAMINS | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118939672 | 11893967 | 7 | C | I RON | FERROUS FUMARATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118939672 | 11893967 | 8 | C | RIFAMPICIN | RIFAMPIN | 1 | Unknown | U | 0 | ||||||||||
| 118939672 | 11893967 | 9 | C | ISONIAZID. | ISONIAZID | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118939672 | 11893967 | 1 | Product used for unknown indication |
| 118939672 | 11893967 | 2 | Antiretroviral therapy |
| 118939672 | 11893967 | 3 | Product used for unknown indication |
| 118939672 | 11893967 | 4 | Antiretroviral therapy |
| 118939672 | 11893967 | 5 | Product used for unknown indication |
| 118939672 | 11893967 | 6 | Product used for unknown indication |
| 118939672 | 11893967 | 7 | Product used for unknown indication |
| 118939672 | 11893967 | 8 | Prophylaxis |
| 118939672 | 11893967 | 9 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118939672 | 11893967 | CA |
| 118939672 | 11893967 | OT |
| 118939672 | 11893967 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118939672 | 11893967 | Blood lactic acid increased | |
| 118939672 | 11893967 | Foetal exposure during pregnancy | |
| 118939672 | 11893967 | Hypotonia | |
| 118939672 | 11893967 | Macrocephaly | |
| 118939672 | 11893967 | Macrocytosis | |
| 118939672 | 11893967 | Neutropenia | |
| 118939672 | 11893967 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118939672 | 11893967 | 3 | 19981211 | 0 |